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Objectives: Retrospective analysis of the oncological results and morbidity of ethmoid sinus
adenocarcinoma surgery, and identiﬁcation of survival factors.
Material and methods: Forty-two patients were treated from 1990 to 2009. The study covered
clinical presentation, medical imaging, histologic data, TNM grade, treatment, morbidity and
overall recurrence-free survival.
Results: Forty-one men and one woman, with mean age at diagnosis of 61.5 years, were
included. 85.7% had been exposed to wood dust. Twenty patients (47.6%) were graded T4 at diag-
nosis. Thirty-three (78.5%) were treated by surgery followed by radiation therapy; nearly half of
these showed recurrence. Overall speciﬁc 5-year survival was 44.2% at 5 years and recurrence-
free 5-year survival 46.4%. The factors of poor prognosis found were cerebromeningeal or orbital
invasion and local recurrence.
Conclusion: This series conﬁrms the epidemiological literature on ethmoid adenocarcinoma and
the inﬂuence of poor prognosis factors. Survival depended directly on local tumor control and
seemed to be enhanced on an isolated transfacial approach.





In France, the incidence of facial sinus cancer is less than
1/100,000 per year [1] and 70% to 80% of malignant ethmoid
tumors are adenocarcinomas [2]. Clinical signs are poorly
speciﬁc and appear only at an advanced stage, whence the
high rate of grades T3 and T4. Surgery followed by exter-
nal radiation therapy is the current attitude of choice. The
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doi:10.1016/j.anorl.2011.02.012resent study retrospectively assessed oncologic results and
orbidity for various treatments and on various surgical
pproaches. The secondary objective was to identify sur-
ival factors.
atients and methods
his retrospective study systematically reviewed the
ecords of ethmoid adenocarcinoma patients treated and
ollowed up in the ENT department of Angers Univer-
ity Hospital (France) between 1990 and 2009. Patients










































































































denocarcinoma of other paranasal sinuses were excluded.
he data collected concerned symptomatology, radiolog-
cal lesion characteristics (TNM grade on the 1997 UICC
lassiﬁcation) and management. The WHO histological
lassiﬁcation [3] was used. Evolution and recurrence char-
cteristics and treatment were recorded.
Data were analyzed on SPSS 13.0 software. Qualitative
ariables were compared on Khi2. Survivorship was calcu-
ated on the Kaplan-Meyer method (end of study: March 1st,
010). Survival was compared between two groups by log
ank and between more than two groups by Cox models. Non-
peciﬁc overall survivorship was based on date of death from
hatever causes or date of last consultation. Speciﬁc overall
urvivorship was based exclusively on disease-related death.
esults were expressed as hazard ratios (HR) with 95% conﬁ-
ence intervals, with an asymptotic signiﬁcance threshold
f p = 5%.
esults
tudy population
he study population comprised 42 patients, including one
emale. Median age at diagnosis was 61.5 years (range,
5—81 years). Median FU was 2 years 5 months (range, 10
ays to 19 years 10 months).
Occupation was known for 41 patients, 36 of whom
85.7%) had had occupational exposure to wood dust, and
one to leather. When speciﬁed, exposure time was a mean
0.4± 14 years. The mean interval between end of exposure
nd diagnosis of ethmoid adenocarcinoma was 10.9 years.
he remaining patients had exposure to no known risk fac-
ors, except for one who worked in metallurgy, although
ickel exposure was not speciﬁed. Initial American Society
f Anesthesiologists score (ASA: predictive of perioperative
orbidity-mortality) was 1 for 83% of patients, 2 for 12% and
for 5%.
iagnosis
t initial diagnosis, evolution was for a mean 5.6± 4months.
nitial symptoms, in order of frequency, were epistaxis
71%), nasal obstruction (64%), rhinorrhea (33%) and anosmia
26%).
CT and MRI were performed in all but one patient (CT
nly). 11.9% of tumors were T1 (5/42), 31% T2 (13/42), 9.5%
3 (4/42) and 47.6% T4 (20/42). There were no cases of
ymph-node invasion or diagnostic-stage metastasis. There
as no correlation between tumor grade and time of evolu-
ion (p = 0.73) or of wood dust exposure (p = 0.19). All tumors
ere intestinal type adenocarcinomas (ITAC): 40.5% muci-
ous, 26% colonic, 7.1% papillary and 2.4% solid; histologic
ubtype was unspeciﬁed in 24% of patients.
reatmenthe surgical approaches were: mixed (sub-frontal and
aralateronasal [PLN]), isolated PLN, Labayle’s enlarged PLN
s modiﬁed by Vaneecloo [4,5] and nasal endoscopic. In
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echniques: temporal aponeurosis with an inferior-hinged
ediculated galea aponeurotica ﬂap or rectus abdominis
uscle aponeurosis with abdominal fat graft.
Thirty-ﬁve of the patients (83%) were operated on,
ith the following approaches: 14 PLN, 11 enlarged PLN
ncluding seven with skull base resection, eight mixed, one
solated sub-frontal and one associating nasal endoscopic
nd sub-frontal. Mean hospital stay was 11.3± 10 days.
ean diagnosis-to-surgery time was 6.4± 3weeks. Table 1
resents the postoperative complications. Apart from one
ase of meningitis and one convulsive attack, both fol-
owing surgery on a PLN approach, all neurosurgical
omplications were secondary to a mixed approach. Apart
rom the convulsive attack, all were secondary to skull
ase reconstruction by galea aponeurotica ﬂap with tem-
oral aponeurosis. There were no late complications. Two
atients operated on using a mixed approach did not
ndergo postoperative radiation therapy, due to death: one
n day 10 following coma related to hydrocephalus and
rontotemporal ischemia, and one at 9 weeks following
nexplained deterioration in general health status. Preop-
rative neoadjuvant chemotherapy was performed in four
f the 35 operated patients (5-ﬂuorouracil associated to
isplatin, by general route). In the 33 patients receiving
ostoperative radiation therapy, the mean surgery-to-
adiation interval was 6.12± 2weeks, with a mean
ose of 60Gy. Seven patients could not be operated
n due to poor general health status or tumor exten-
ion. All operated patients were considered as treated.
one of the seven non-operated patients were consid-
red as in remission: one died after admission for coma,
ithout receiving treatment; two died during induction
hemotherapy; one died after radiochemotherapy; and
hree were in evolution after radiochemotherapy at end of
ollow-up. These patients were not included in the analysis
f recurrence.
volution
leven of the 35 patients operated on (31.4%) showed
ocal recurrence, two (5.7%) metastasis, and three (8.6%)
ocal and metastatic recurrence. Mean recurrence inter-
al was 13 months (range, 8.7—28.5months). There was no
ervical lymph-node invasion associated with recurrence.
etastasis was intracerebral in two patients, hepatic in
ne, osseous in one and cutaneous in one. The recurrence
ate was 100% (eight patients) with a mixed approach,
nd 18.8% (11 patients) with an enlarged PLN approach
p = 0.02). There was no signiﬁcant difference in T-stage
r tumoral invasion between the two approaches. Thir-
een of the 16 patients with recurrence died (including
ne from intercurrent causes) at a mean 3.7 years. Two
atients were in remission after surgical revision for focal
ecurrence, at respectively 18 and 6 years’ FU, and one
as in local evolution at end of follow-up. No recur-
ence risk factors emerged from the study variables: age
t diagnosis (p = 0.42), T-stage (p = 0.55), orbital invasion
p = 0.2), dura-mater invasion (p = 0.2), cerebral invasion
p = 0.55), sphenoid invasion (p = 0.58), histologic subtype
p = 0.86), or surgery-to-radiation therapy time (p = 0.75). At
nd of follow-up, 21 patients had died (including three from
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Table 1 Immediate postoperative complications (less than 2 weeks).
Complications (n = 35) % (n) Approach Skull base reconstruction
(speciﬁed for neurosurgical
complications)
No complications 60 (21)
Meningitis 2.8 (1) PLN No skull base resection
Rhinoliquorrhea 5.7 (2) Mixed Temporal aponeurosis and
pediculated galea aponeurotica
Intracerebral hematoma 2.8 (1) Mixed Temporal aponeurosis and
pediculated galea aponeurotica
Non-regressive diplopia at 2 weeks 11.4 (4) 2 PLN, 2 mixed −
Epilepsy 2.8 (1) Enlarged PLN Rectus abdominis aponeurosis
and fat patch
Extradural abscess 2.8 (1) Mixed Temporal aponeurosis and
pediculated galea aponeurotica
Dacryocystitis 5.7 (2) PLN −
Local infection 2.8 (1) PLN −










tTotal complications 40 (14)
unrelated causes), 21 were alive (including three with evo-
lution). Mean time to death was 3 years 2 months (median
survival, 29 months).
Survival
Table 2 shows survival and recurrence rates. Speciﬁc and
non-speciﬁc overall 1-, 3- and 5-year survival was respec-
tively 82% and 83%, 64% and 60%, and 44% and 41%.
Exophthalmia, reduced visual acuity, headache and anosmia
at diagnosis emerged as factors for poor prognosis. Figure 1
shows the speciﬁc survival curve according to recurrence.





(Figure 2 shows the survival curve according to T-grade.
verall 5-year survival was 100% in T1, 49.1% in T2, 50%
n T3 and 21% in T4. Orbital and cerebromeningeal inva-
ion emerged as factors for poor prognosis (p < 0.01). The
azard ratio for orbital involvement was 1.62 (95% CI,
1.06;3.18]); for dura-mater involvement, 5.27 (95% CI,
1.93;14.41]); and for cerebral involvement, 6.42 (95%
I, [2.34;17.6]). Maxillary or sphenoid sinus involvement
id not affect survival (p = 0.72 and p = 0.59, respec-
ively).Survival was signiﬁcantly lower in non-operated patients
han in those undergoing surgery and radiation ther-
py (overall 3-year survival, 28.6% vs. 71.6%; p < 0.05).
igure 2 Overall speciﬁc survivorship according to T grade
p = 0.08).
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p 5-year survival p
Age
< 61.5 years 21 50 0.42 48.5 0.62
> 61.5 years 21 41 37.9
Wood-dust exposure
Yes 36 43.3 0.6 37.8 0.88
No 5 50 60
T grade
1 5 40 0.55 100 0.083
2 13 38.4 49.1
3 4 50 50
4 20 54 21
Orbital invasion
No 25 37.5 0.2 59.4 < 0.01
Muscles intact 10 62.5 36.5
Muscles invaded 7 66.6 16.7
Sphenoid invasion
Yes 3 33.3 0.58 0 0.59
No 39 46.8 45.1
Maxillary invasion
Yes 7 42.8 0.6 45.7 0.72
No 35 46.4 43.2
Meningeal invasion
Yes 18 63.6 0.2 9.2 < 0.01
No 24 37.5 69.1
Cerebral invasion
Yes 11 60 0.55 0 < 0.01
No 31 43.3 59
Treatment
Surgery and radiation 33 43.7 − 53.7 < 0.01
PLN approach 14 35.7 0.02 75 < 0.01
Mixed approach 8 100 0.02 12.5 < 0.01
Enlarged PLN 11 18.8 0.02 100 < 0.01
Surgery only 2 Postoperative death — 0 < 0.01
Other 7 — — 0 < 0.01
Recurrence (n = 35)
















sLocoregional recurrence 11 —
Recurrence with metastasis 5 —
urvival according to surgery, calculated for enlarged PLN
nd mixed approaches, showed a signiﬁcant difference in
avor of the enlarged PLN approach (p < 0.01). The distri-
ution of poor prognosis factors was similar in the two
pproach groups.
iscussionhe low incidence of adenocarcinoma of the ethmoid has
o far prevented any prospective randomized study. All






indered by disparities: variable histology, inclusion of ade-
ocarcinoma of other paranasal sinuses, and varying surgical
pproaches. Table 3 presents the series published in the last
0 years, non-exhaustively.
The present epidemiological data (sex ratio, age at diag-
osis and wood-dust exposure) were in agreement with the
iterature. They show the importance of wood-dust expo-
ure (85.7% of cases) and of long exposure in particular
30.4 years in the present series; 22—31.5 years in the lite-
ature). Risk, however, seems to exist as of the ﬁrst years
f exposure: 2 years, in the case of one of the present
atients.
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Table 3 Review of retrospective ethmoid adenocarcinoma series since 2000.
Author, place, date n (m/f) Age (years) Wood-dust
exposure (%)




T1 T2 T3 T4
De Gabory, Bordeaux [15] 2010 87/8 64 73 2 22 37 39 78 31
Mayr, Erlangen [16] 2009 31 − 32 − − − − − −
Choussy, GETTEC study [1] 2008 418 63 28 3 32 23 42 64 51
Liétin, Clermont-Ferrand [17] 2005 59/1 62 26 − − − − 47 −
Jegoux, Nantes [9] 2004 78/2 63 67 5 23 31 41 63 44
Michel, Amiens [18] 2003 10 − − − − − − 53 60
Guillotte, Reims [19] 2003 17 − − 0 12 0 88 41 58
Claus, Bruges [20] 2002 47 − 81 4 36 23 36 60 −
Dulguerov, Los Angeles [21] 2001 25 − − − − − − 63 −
Choussy, Rouen [22] 2001 19 57 − 0 37 50 13 69 −
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Clinical presentation was poorly speciﬁc. Hemorrhagic
rhinorrhea and nasal obstruction were prime features. The
very ordinariness of these symptoms explains why diagno-
sis is often delayed and why most series include few small
tumors.
There is now consensus as to the reference attitude in
adenocarcinoma of the ethmoid, based on surgery associa-
ted to postoperative adjuvant radiation therapy, as in 78.5%
of the present series. This association improves local control
and overall and recurrence-free survival [6]. The approach
depends on oncologic requirements, notably as concerns
skull base resection and the team’s particular habits. Cer-
tain authors [7] distinguish four groups of tumors, according
to Roux’s TNM classiﬁcation [8]. In the ﬁrst (T1 and T2), the
skull based is unaffected, and the approach should be lateral
rhinotomy. In the second (T3), the tumor touches without
invading the cribiform plate; classically, the approach is
paralateronasal without skull base resection, while trimming
the cribiform plate to ensure against invasion; the authors,
however, recommend systematic skull base resection here,
as non-invasion is difﬁcult to conﬁrm on radiography or his-
tology. In the third group (T4a), the tumor invades only the
cribiform plate, and systematic skull base and meningeal
resection is recommended. In the last group (T4b), the dura
mater or even the frontal lobes show clear invasion: surgery
is not an obvious option, due to deﬁcient local control.
In the present series, cribiform plate invasion was ini-
tially dealt with on a mixed approach, reserving a PLN
approach for lesions without skull base extension. The
enlarged PLN approach has nowadays largely replaced
the mixed approach, with indications being progressively
extended to cribiform plate resection. By simplifying the
procedure, this approach may have extended indications for
skull base resection, thereby improving local control.
This variant PLN approach was introduced by Moure
and Sebilleau then modiﬁed by Labayle in 1957 and again
by Vaneecloo [5], who recommended extending incision
outward above the eyebrow so as to be able to control
the entire cribiform plate and ethmoid roofs. In agree-
ment with several authors [7,9], we ﬁnd that it provides
a satisfactory approach to the skull base and sinonasal
a
s
b85 12 31 9 48 44.2 46
avities while reducing esthetic blemish and morbidity-
ortality as compared to a mixed approach. Most
eurosurgical complications in the present series were asso-
iated with a mixed approach, which in the literature is
ssociated with a higher rate of postoperative neurologi-
al and infectious complication than a transfacial approach,
nd with mortality ranging from 0 to 11% [7]. A mixed
pproach does, however, allow exeresis of tumors that could
ot be removed on an enlarged PLN approach (cerebral or
terygomaxillary fossa involvement), although this has not
een demonstrated to improve survival rates. Finally, over-
ll and recurrence-free survival were enhanced using an
nlarged transfacial approach in the present series (over-
ll 5-year survival 100% vs. 12.5%, respectively). Although
here were no signiﬁcant differences in prognostic factors
etween the mixed and enlarged PLN groups, these results
hould still be interpreted with caution: a mixed approach
as probably indicated for more extensive tumors with more
ifﬁcult local control. The lower morbidity associated with
he enlarged PLN approach may have enabled indications for
kull base resection to be extended, particularly in elderly
atients (who would not have been operated on with a mixed
pproach) or in tumors with simple cribiform plate contact.
Endoscopy has recently been suggested as an alterna-
ive to lateral rhinotomy [10,11], providing easy access to
he olfactory cleft, which is probably the starting point
f adenocarcinoma of the ethmoid [12]. Certain authors
12,13] consider that this approach, thanks to the deve-
opment of image-guided sinus surgery, can now meet the
ame oncologic requirements as open ethmoid adenocarci-
oma exeresis. The endoscopic approach should begin by
educing tumor volume, followed by total bilateral eth-
oidectomy, before dissecting the olfactory clefts. The
ontribution of this technique remains hard to assess, as
eries have been relatively small (18 and 12 patients,
espectively [10,11]) and follow-up short (25 and 34
onths).
Although complications are rare on an enlarged PLN
pproach, postoperative morbidity very much depends on
kull base reconstruction quality. Several methods have
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ura-mater patch should be created using, say, rectus abdo-
inis aponeurosis graft [7] or an inferior-hinged pediculated
picranial ﬂap. Temporal fascia, fascia lata or Neuro-Patch®
polyester-urethane) have been suggested as alternatives.
The technique used in the present series was based on
hat of Reyt [14] as modiﬁed by the team from Nantes [7].
ural reconstruction uses a rectus abdominis aponeurosis
raft. An abdominal fat patch is then applied, kept in place
y a silicone arch. This simple reconstruction technique
eems to be an excellent compromise between reliability
nd rapidity. In the present series, it was associated with a
ower neurologic complications rate than for epicranial ﬂap
nd temporal aponeurosis graft reconstruction.
In the present series, 45.7% of patients showed recur-
ence at a mean 26 months, in line with literature reports
51% recurrence at a mean 28 months in the GETTEC study
1]). The recurrence risk factors classically described (T4
rade and skull base invasion) were not observed.
The 5-year survival rate was 44.2%, lower than in most
eports. Orbital and skull base invasion emerged as factors
f poor prognosis. There was a signiﬁcant difference in sur-
ival between absence of skull base invasion and meningeal
r cerebral invasion. These ﬁndings conﬁrm the importance
f distinguishing between tumors invading, exceeding or not
nvading or the cribiform plate, and thus the prognostic
alue of Roux’s TNM classiﬁcation TNM [8] and the 2002 UICC
lassiﬁcation. The survival impact of presenting symptoma-
ology (reduced visual acuity, exophthalmia, anosmia and
eadache) conﬁrms their relevance as prognostic factors.
As in the literature, grade T4 directly impacted survival
hazard ratio, 3.7; 95% CI, [1.29;10.6]). Local recurrence
nd metastatic evolution emerged as major risk factors for
oor prognosis.
Given these ﬁndings, the present relatively low survival
ate was probably due to the presence of risk factors for poor
rognosis: 40% orbital invasion, 42.9% dura-mater invasion,
6.2% cerebral invasion, and 47.6% grade-T4 cases, versus
espectively 23%, 15%, 15% and 42% in the GETTEC study [1].
onclusion
denocarcinoma of the ethmoid is a rare tumor, often diag-
osed only at an advanced stage due to prolonged clinical
atency. In these aggressive tumors, local control is the
etermining prognostic factor. The priority is thus primary
omplete exeresis, with the approach determined according
o presence or absence of skull base invasion.
The present results argue for systematic skull base
esection in case of cribiform plate contact. The enlarged
aralateronasal approach is more reliable than a mixed
pproach, in terms of both postoperative morbidity and
ncologic result: survival and recurrence rates were both
onsiderably improved on this isolated transfacial approach.
isclosure of interesthe authors declare that they have no conﬂicts of interest
oncerning this article.
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